Flex Pharma CEO David Arthur's 2020 pay jumps 119% to $1.1M
Flex Pharma reports 2020 executive compensation
By ExecPay News
Published: April 27, 2021
Flex Pharma reported fiscal year 2020 executive compensation information on April 27, 2021.
In 2020, two executives at Flex Pharma received on average a compensation package of $828K, a 73% increase compared to previous year.
Average pay of disclosed executives at Flex Pharma
David J. Arthur, Chief Executive Officer, received $1.1M in total, which increased by 119% compared to 2019. 53% of Arthur's compensation, or $606K, was in option awards. Arthur also received $85K in bonus, $340K in salary, as well as $106K in other compensation.
Mark J. Rosenblum, Chief Financial Officer, received a compensation package of $520K, which increased by 19% compared to previous year. 51% of the compensation package, or $265K, was in salary.
Related executives
You may also like
Source: SEC filing on April 27, 2021.